Tigermed IPO: Trading Debut
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
416 Views
Haier (1169 HK): Avatar Scrip Offer From Parent
Haier Electronics Group Co (1169 HK) (HEG) was briefly suspended pursuant to the Takeovers Code on the 19 December 2019, which was followed by...
539 Views
Tigermed (泰格医疗) A+H: Past A+H Listings Suggest Upside Might Be Limited
Tigermed, the largest China-based clinical CRO company, launched book building today to raise up to USD 1.4 bn to list in Hong Kong. In our...
409 Views
Tigermed IPO: Valuation Insights
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
419 Views
Tigermed (泰格医疗) A+H: PHIP Updates and Thoughts on Valuation
Hangzhou Tigermed, a leading China-based CRO company, is seeking a USD 1.5 bn H-share listing in Hong Kong. In our previous note, we discussed that...
458 Views